Quantcast

Latest neck cancers Stories

2012-01-23 21:55:05

Researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center, the University Hospital for Einstein, have found a biomarker in head and neck cancers that can predict whether a patient's tumor will be life threatening. The biomarker is considered particularly promising because it can detect the level of risk immediately following diagnosis. This discovery could become a component of a new test to guide how aggressively those with head and neck tumors...

2011-09-13 12:00:15

Study could have an impact in fighting head and neck cancers Curcumin, the main component in the spice turmeric, suppresses a cell signaling pathway that drives the growth of head and neck cancer, according to a pilot study using human saliva by researchers at UCLA's Jonsson Comprehensive Cancer Center. The inhibition of the cell signaling pathway also correlated with reduced expression of a number of pro-inflammatory cytokines, or signaling molecules, in the saliva that promote cancer...

2011-04-26 14:55:33

Human papillomavirus (HPV) causes cervical cancer, the second most common cause of cancer death for women, and is a common cause of anogenital and some head and neck cancers. Thanks to research being done at Tufts University School of Medicine, patients infected with cancer-causing HPV may someday have an alternative to surgical and harsh chemical treatments. In a study funded by the National Institutes of Health and published online in advance of print in The FASEB Journal, the researchers...

2011-04-06 08:00:00

NEW YORK, April 6, 2011 /PRNewswire/ -- Academy Award-winning actor and producer Michael Douglas, who is recovering from a battle with throat cancer, is urging Americans to get screened for cancer during the 14th annual Oral, Head & Neck Cancer Awareness Week (OHANCAW), being held nationwide May 8-14 . More than 200 medical centers across the country and the world will offer free oral, head and neck cancer screenings during OHANCAW, which is sponsored by the Head and Neck Cancer...

2011-03-24 06:30:00

CALGARY, March 24 /PRNewswire/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX: ONC, NASDAQ: ONCY) today announced that it has completed patient enrollment in its U.S. Phase 2 clinical trial (REO 015) using intravenous administration of REOLYSIN in combination with paclitaxel and carboplatin in patients with advanced head and neck cancers. "This study was performed in part to confirm the results of our UK Phase II study, which enrolled a slightly different patient population, and to...

2011-02-28 07:00:00

SAN ANTONIO, Feb. 28, 2011 /PRNewswire/ -- Advanced Cell Diagnostics, Inc. (ACD) today announced the results of its clinical study utilizing RNAscope(TM) technology to detect human papillomavirus (HPV) E6/E7 mRNA in routine clinical specimens of head and neck cancer. HPV status determined by the RNAscope(TM) HPV test was highly predictive of patient outcome and highly concordant with that determined by existing methods. Significantly, the RNAscope(TM) test under development demonstrated...

2011-02-16 16:16:52

Smokers who continue to smoke while undergoing radiation treatments for head and neck cancer fare significantly worse than those who quit smoking before therapy, according to a study in the February issue of the International Journal of Radiation Oncology"¢Biology"¢Physics, an official journal of the American Society for Radiation Oncology (ASTRO). Although the association between tobacco smoking and head and neck cancers has long been established, there had been little data...

2010-11-10 06:30:00

CALGARY, Nov. 10 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:ONCY) ("Oncolytics" or the "Company") today announced its financial results and operational highlights for the quarter ended September 30, 2010. "We are excited to be conducting our first Phase 3 study," said Dr. Brad Thompson, President and CEO of Oncolytics.  "Moving into the fourth quarter the Company's fundamentals remain strong and we are well positioned to execute on our clinical strategy in...

2010-11-04 13:12:27

Stereotactic body radiotherapy (SBRT), a radiation therapy procedure pioneered at the University of Pittsburgh Cancer Institute (UPCI) that precisely delivers a large dose of radiation to tumors, may effectively control and treat head and neck cancers when combined with the chemotherapy Cetuximab, according to researchers from UPCI. The results of the research will be presented today at the American Society for Radiation Oncology (ASTRO) annual meeting in San Diego. The study, led by Dwight...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related